A Framework for Risk-Benefit Evaluations in Biomedical Research
Essentially all guidelines and regulations require that biomedical research studies have an acceptable risk-benefit profile. However, these documents offer little concrete guidance for implementing this requirement and determining when it is satisfied. As a result, those charged with risk-benefit ev...
| Authors: | ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Johns Hopkins Univ. Press
2011
|
| In: |
Kennedy Institute of Ethics journal
Year: 2011, Volume: 21, Issue: 2, Pages: 141-179 |
| Online Access: |
Presumably Free Access Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000naa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1826984100 | ||
| 003 | DE-627 | ||
| 005 | 20221214052544.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221214s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1353/ken.2011.0007 |2 doi | |
| 035 | |a (DE-627)1826984100 | ||
| 035 | |a (DE-599)KXP1826984100 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Rid, Annette |e VerfasserIn |4 aut | |
| 109 | |a Rid, Annette | ||
| 245 | 1 | 2 | |a A Framework for Risk-Benefit Evaluations in Biomedical Research |
| 264 | 1 | |c 2011 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Essentially all guidelines and regulations require that biomedical research studies have an acceptable risk-benefit profile. However, these documents offer little concrete guidance for implementing this requirement and determining when it is satisfied. As a result, those charged with risk-benefit evaluations currently assess the risk-benefit profile of biomedical research studies in unsystematic ways, raising concern that some research participants are not being protected from excessive risks and that some valuable studies involving acceptable risk are being rejected. The present paper aims to address this situation by delineating the first comprehensive framework, which is based on existing guidelines and regulations as well as the relevant literature, for risk-benefit evaluations in biomedical research. | ||
| 700 | 1 | |a Wendler, David |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a Kennedy Institute of Ethics |t Kennedy Institute of Ethics journal |d Baltimore, Md. : Johns Hopkins Univ. Press, 1991 |g 21(2011), 2, Seite 141-179 |h Online-Ressource |w (DE-627)320481840 |w (DE-600)2009887-X |w (DE-576)266818668 |x 1086-3249 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2011 |g number:2 |g pages:141-179 |
| 856 | |u https://www.zora.uzh.ch/id/eprint/54897/1/2011_Rid_A_A_Framework_for_Risk-Benefit_Evaluations.pdf |x unpaywall |z Vermutlich kostenfreier Zugang |h repository [oa repository (via OAI-PMH doi match)] | ||
| 856 | 4 | 0 | |u https://doi.org/10.1353/ken.2011.0007 |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://muse.jhu.edu/pub/1/article/439953 |x Verlag |z lizenzpflichtig |3 Volltext |
| 935 | |a mteo | ||
| 936 | u | w | |d 21 |j 2011 |e 2 |h 141-179 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 423089497X | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1826984100 | ||
| LOK | |0 005 20221214052544 | ||
| LOK | |0 008 221214||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2022-12-05#4043542CB887C3CD4E36EAF3597A15F62C7033CD | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a ixrk |a zota | ||
| OAS | |a 1 | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||